Theravance Biopharma (TBPH) Price to Sales (2014 - 2026)
Theravance Biopharma's (TBPH) Price to Sales came in at 8.46 for Q2 2026, up 17.5% from 7.19 a year earlier and up 11.0% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Price to Sales (2014 - 2026) Analysis & Trends
For FY2025, Theravance Biopharma's Price to Sales stood at 8.89, up 23.0% from FY2024.
- In prior years, Theravance Biopharma's Price to Sales was 7.23 in FY2024 (-23.2%), 9.41 in FY2023 (-34.0%), 14.25 in FY2022 (-4.2%) and 14.87 in FY2021 (-6.5%).
- Quarterly Price to Sales has run from a low of 6.27 in Q3 2024 to a high of 14.87 in Q4 2021 over five years.
- On a year-over-year basis, Price to Sales has increased in each of the last five quarters, with growth averaging 7.2% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q3 2025, with growth of 46.8%; the weakest was Q1 2024, with a decline of 47.6%.
- According to Business Quant data, Price to Sales for the three prior quarters was 7.62 (Q1 2026), 8.89 (Q4 2025) and 9.21 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.46 |
| Mar 31, 2026 | 7.62 |
| Dec 31, 2025 | 8.89 |
| Sep 30, 2025 | 9.21 |
| Jun 30, 2025 | 7.19 |
| Mar 31, 2025 | 6.84 |
| Dec 31, 2024 | 7.23 |
| Sep 30, 2024 | 6.27 |
| Jun 30, 2024 | 6.69 |
| Mar 31, 2024 | 7.08 |
| Dec 31, 2023 | 9.41 |
| Sep 30, 2023 | 8.05 |
| Jun 30, 2023 | 10.84 |
| Mar 31, 2023 | 13.53 |
| Dec 31, 2022 | 14.25 |
| Sep 30, 2022 | 13.23 |
| Jun 30, 2022 | 13.22 |
| Mar 31, 2022 | 13.41 |
| Dec 31, 2021 | 14.87 |
| Sep 30, 2021 | 9.23 |
API Access
Theravance Biopharma Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();